{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:43:14Z","timestamp":1792600994251,"version":"4.5.0"},"reference-count":64,"publisher":"MyJove Corporation","issue":"211","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/67421","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T20:00:21Z","timestamp":1726862421000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification"],"prefix":"10.3791","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-lei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","type":"journal-article","article-title":"Genetics and epigenetics of primary sjogren syndrome: Implications for future therapies","volume":"19","author":"Thorlacius","year":"2023","unstructured":"Thorlacius, G. E., Bjork, A., Wahren-Herlenius, M. Genetics and epigenetics of primary sjogren syndrome: Implications for future therapies. Nat Rev Rheumatol. 19 (5), 288-306 (2023).","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","type":"journal-article","article-title":"Primary Sjogren's syndrome and the eye","volume":"65","author":"Bjordal","year":"2020","unstructured":"Bjordal, O., Norheim, K. B., Rodahl, E., Jonsson, R., Omdal, R. Primary Sjogren's syndrome and the eye. Surv Ophthalmol. 65 (2), 119-132 (2020).","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/mr\/road010","type":"journal-article","article-title":"Hyperglobulinemia predicts increased risk of mortality in primary Sjogren's syndrome: Based on a Chinese multicentre registry","volume":"34","author":"Zhong","year":"2023","unstructured":"Zhong, H. et al. Hyperglobulinemia predicts increased risk of mortality in primary Sjogren's syndrome: Based on a Chinese multicentre registry. Mod Rheumatol. 34 (1), 137-143 (2023).","journal-title":"Mod Rheumatol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12890-022-01868-5","type":"journal-article","article-title":"Interstitial lung disease in primary Sjogren's syndrome","volume":"22","author":"Lin","year":"2022","unstructured":"Lin, W. et al. Interstitial lung disease in primary Sjogren's syndrome. BMC Pulm Med. 22 (1), 73 (2022).","journal-title":"BMC Pulm Med"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40744-020-00264-x","type":"journal-article","article-title":"Renal disease in primary Sjogren's syndrome","volume":"8","author":"Aiyegbusi","year":"2021","unstructured":"Aiyegbusi, O. et al. Renal disease in primary Sjogren's syndrome. Rheumatol Ther. 8 (1), 63-80 (2021).","journal-title":"Rheumatol Ther"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ene.15555","type":"journal-article","article-title":"Primary sjogren syndrome-related peripheral neuropathy: A systematic review and meta-analysis","volume":"30","author":"Liampas","year":"2023","unstructured":"Liampas, A. et al. Primary sjogren syndrome-related peripheral neuropathy: A systematic review and meta-analysis. Eur J Neurol. 30 (1), 255-265 (2023).","journal-title":"Eur J Neurol"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.21037\/atm-22-162","type":"journal-article","article-title":"Clinical and laboratory features of primary Sjogren's syndrome complicated with mild to severe thrombocytopenia","volume":"10","author":"Wu","year":"2022","unstructured":"Wu, J. et al. Clinical and laboratory features of primary Sjogren's syndrome complicated with mild to severe thrombocytopenia. Ann Transl Med. 10 (6), 300 (2022).","journal-title":"Ann Transl Med"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"103084","DOI":"10.1016\/j.autrev.2022.103084","type":"journal-article","article-title":"Primary Sjogren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis","volume":"21","author":"Zhong","year":"2022","unstructured":"Zhong, H. et al. Primary Sjogren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis. Autoimmun Rev. 21 (5), 103084 (2022).","journal-title":"Autoimmun Rev"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"102987","DOI":"10.1016\/j.autrev.2021.102987","type":"journal-article","article-title":"Cancer incidence in primary Sjogren's syndrome: Data from the French hospitalization database","volume":"20","author":"Goulabchand","year":"2021","unstructured":"Goulabchand, R. et al. Cancer incidence in primary Sjogren's syndrome: Data from the French hospitalization database. Autoimmun Rev. 20 (12), 102987 (2021).","journal-title":"Autoimmun Rev"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1007\/s00262-023-03565-6","type":"journal-article","article-title":"Chronological interplay, clinical features, and treatments among patients with cancer and primary Sjogren's syndrome","volume":"72","author":"Witkowski Durand Viel","year":"2023","unstructured":"Witkowski Durand Viel, P. et al. Chronological interplay, clinical features, and treatments among patients with cancer and primary Sjogren's syndrome. Cancer Immunol Immunother. 72 (12), 4309-4322 (2023).","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/1759-7714.12216","type":"journal-article","article-title":"The prevalence and clinical characteristics of primary Sjogren's syndrome patients with lung cancer: An analysis of ten cases in China and literature review","volume":"6","author":"Xu","year":"2015","unstructured":"Xu, Y. et al. The prevalence and clinical characteristics of primary Sjogren's syndrome patients with lung cancer: An analysis of ten cases in China and literature review. Thorac Cancer. 6 (4), 475-479 (2015).","journal-title":"Thorac Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2147\/CCID.S421193","type":"journal-article","article-title":"Bioinformatics and systems biology approach to identify the pathogenetic link between psoriasis and cardiovascular disease","volume":"16","author":"Shi","year":"2023","unstructured":"Shi, L., Du, X., Li, J., Zhang, G. Bioinformatics and systems biology approach to identify the pathogenetic link between psoriasis and cardiovascular disease. Clin Cosmet Investig Dermatol. 16, 2283-2295 (2023).","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"e20220874","DOI":"10.36660\/abc.20220874","type":"journal-article","article-title":"Bioinformatics and systems biology approach to identify the pathogenetic link between heart failure and sarcopenia","volume":"120","author":"Xu","year":"2023","unstructured":"Xu, R., Ma, L. L., Cui, S., Chen, L., Xu, H. Bioinformatics and systems biology approach to identify the pathogenetic link between heart failure and sarcopenia. Arq Bras Cardiol. 120 (10), e20220874 (2023).","journal-title":"Arq Bras Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"952987","DOI":"10.3389\/fimmu.2022.952987","type":"journal-article","article-title":"Bioinformatics and systems biology approach to identify the pathogenetic link of long COVID and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"13","author":"Lv","year":"2022","unstructured":"Lv, Y. et al. Bioinformatics and systems biology approach to identify the pathogenetic link of long COVID and myalgic encephalomyelitis\/chronic fatigue syndrome. Front Immunol. 13, 952987 (2022).","journal-title":"Front Immunol"},{"issue":"database issue","key":"ref15","first-page":"D991","type":"journal-article","article-title":"Ncbi geo: Archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","unstructured":"Barrett, T. et al. Ncbi geo: Archive for functional genomics data sets--update. Nucleic Acids Res. 41 (Database issue), D991-995 (2013).","journal-title":"Nucleic Acids Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","type":"journal-article","article-title":"The GeneCards suite: From gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","unstructured":"Stelzer, G. et al. The GeneCards suite: From gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 54, 1.30.1-1.30.33 (2016).","journal-title":"Curr Protoc Bioinformatics"},{"key":"ref17","first-page":"e62528","type":"journal-article","article-title":"Three differential expression analysis methods for RNA sequencing: limma, EdgeR, DESeq2","volume":"175","author":"Liu","year":"2021","unstructured":"Liu, S. et al. Three differential expression analysis methods for RNA sequencing: limma, EdgeR, DESeq2. J Vis Exp. 175, e62528 (2021).","journal-title":"J Vis Exp"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","type":"journal-article","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 10 (1), 1523 (2019).","journal-title":"Nat Commun"},{"issue":"D1","key":"ref19","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","type":"journal-article","article-title":"The string database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The string database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51 (D1), D638-D646 (2023).","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","type":"journal-article","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13 (11), 2498-2504 (2003).","journal-title":"Genome Res"},{"issue":"7955","key":"ref21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-023-05874-3","type":"journal-article","article-title":"Lung adenocarcinoma promotion by air pollutants","volume":"616","author":"Hill","year":"2023","unstructured":"Hill, W. et al. Lung adenocarcinoma promotion by air pollutants. Nature. 616 (7955), 159-167 (2023).","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"110254","DOI":"10.1016\/j.intimp.2023.110254","type":"journal-article","article-title":"PM2.5 exposure regulates th1\/th2\/th17 cytokine production through NF-\u03ba\u03b2 signaling in combined allergic rhinitis and asthma syndrome","volume":"119","author":"Piao","year":"2023","unstructured":"Piao, C. H. et al. PM2.5 exposure regulates th1\/th2\/th17 cytokine production through NF-\u03ba\u03b2 signaling in combined allergic rhinitis and asthma syndrome. Int Immunopharmacol. 119, 110254 (2023).","journal-title":"Int Immunopharmacol"},{"key":"ref23","first-page":"e1610","type":"journal-article","article-title":"Microvolume protein concentration determination using the nanodrop 2000c spectrophotometer","volume":"33","author":"Desjardins","year":"2009","unstructured":"Desjardins, P., Hansen, J. B., Allen, M. Microvolume protein concentration determination using the nanodrop 2000c spectrophotometer. J Vis Exp. 33, e1610 (2009).","journal-title":"J Vis Exp"},{"issue":"12","key":"ref24","first-page":"2373","type":"journal-article","article-title":"Distinct clinical phenotypes of primary Sjogren's syndrome differ by onset age: A retrospective study of 742 cases and review of the literature","volume":"40","author":"Luo","year":"2022","unstructured":"Luo, J. et al. Distinct clinical phenotypes of primary Sjogren's syndrome differ by onset age: A retrospective study of 742 cases and review of the literature. Clin Exp Rheumatol. 40 (12), 2373-2380 (2022).","journal-title":"Clin Exp Rheumatol"},{"issue":"157","key":"ref25","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0021-2020","type":"journal-article","article-title":"Lung complications of Sjogren syndrome","volume":"29","author":"Luppi","year":"2020","unstructured":"Luppi, F. et al. Lung complications of Sjogren syndrome. Eur Respir Rev. 29 (157), (2020).","journal-title":"Eur Respir Rev"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3390\/jcm12072586","type":"journal-article","article-title":"Interstitial lung disease and pulmonary damage in primary Sjogren's syndrome: A systematic review and meta-analysis","volume":"12","author":"Berardicurti","year":"2023","unstructured":"Berardicurti, O. et al. Interstitial lung disease and pulmonary damage in primary Sjogren's syndrome: A systematic review and meta-analysis. J Clin Med. 12 (7), 2586 (2023).","journal-title":"J Clin Med"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","type":"journal-article","article-title":"Interstitial lung disease in primary Sjogren's syndrome","volume":"16","author":"Roca","year":"2017","unstructured":"Roca, F. et al. Interstitial lung disease in primary Sjogren's syndrome. Autoimmun Rev. 16 (1), 48-54 (2017).","journal-title":"Autoimmun Rev"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.rcl.2022.06.010","type":"journal-article","article-title":"Diagnosis and treatment of lung cancer in the setting of interstitial lung disease","volume":"60","author":"Fisher","year":"2022","unstructured":"Fisher, D. A. et al. Diagnosis and treatment of lung cancer in the setting of interstitial lung disease. Radiol Clin North Am. 60 (6), 993-1002 (2022).","journal-title":"Radiol Clin North Am"},{"issue":"3","key":"ref29","first-page":"120","type":"journal-article","article-title":"Implications of thyroid transcription factor-1 gene methylation in carcinogenesis of interstitial pneumonia-related non-terminal respiratory unit lung adenocarcinoma","volume":"15","author":"Okudela","year":"2022","unstructured":"Okudela, K. et al. Implications of thyroid transcription factor-1 gene methylation in carcinogenesis of interstitial pneumonia-related non-terminal respiratory unit lung adenocarcinoma. Int J Clin Exp Pathol. 15 (3), 120-130 (2022).","journal-title":"Int J Clin Exp Pathol"},{"issue":"17","key":"ref30","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/1759-7714.14566","type":"journal-article","article-title":"Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy","volume":"13","author":"Sekine","year":"2022","unstructured":"Sekine, A. et al. Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy. Thorac Cancer. 13 (17), 2443-2449 (2022).","journal-title":"Thorac Cancer"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","type":"journal-article","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","unstructured":"Glaviano, A. et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 22 (1), 138 (2023).","journal-title":"Mol Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semcancer.2019.05.012","type":"journal-article","article-title":"Role of the PI3K\/AKT\/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance","volume":"59","author":"Ediriweera","year":"2019","unstructured":"Ediriweera, M. K., Tennekoon, K. H., Samarakoon, S. R. Role of the PI3K\/AKT\/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance. Semin Cancer Biol. 59, 147-160 (2019).","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","type":"journal-article","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","unstructured":"Hoxhaj, G. Manning, B. D. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 20 (2), 74-88 (2020).","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","type":"journal-article","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","unstructured":"Liu, R. et al. PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis. 11 (9), 797 (2020).","journal-title":"Cell Death Dis"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2174\/1568026623666230111154537","type":"journal-article","article-title":"Impediment of cancer by dietary plant-derived alkaloids through oxidative stress: Implications of PI3K\/AKT pathway in apoptosis, autophagy, and ferroptosis","volume":"23","author":"Manogaran","year":"2023","unstructured":"Manogaran, P., Beeraka, N. M., Paulraj, R. S., Sathiyachandran, P., Thammaiappa, M. Impediment of cancer by dietary plant-derived alkaloids through oxidative stress: Implications of PI3K\/AKT pathway in apoptosis, autophagy, and ferroptosis. Curr Top Med Chem. 23 (10), 860-877 (2023).","journal-title":"Curr Top Med Chem"},{"issue":"23","key":"ref36","doi-asserted-by":"crossref","first-page":"15330","DOI":"10.3390\/ijms232315330","type":"journal-article","article-title":"The PI3K\/AKT pathway in meta-inflammation","volume":"23","author":"Acosta-Martinez","year":"2022","unstructured":"Acosta-Martinez, M. Cabail, M. Z. The PI3K\/AKT pathway in meta-inflammation. Int J Mol Sci. 23 (23), 15330 (2022).","journal-title":"Int J Mol Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5233462","DOI":"10.1155\/2021\/5233462","type":"journal-article","article-title":"Prediction of Rhizoma Drynariae targets in the treatment of osteoarthritis based on network pharmacology and experimental verification","volume":"2021","author":"Chen","year":"2021","unstructured":"Chen, G. Y. et al. Prediction of Rhizoma Drynariae targets in the treatment of osteoarthritis based on network pharmacology and experimental verification. Evid Based Complement Alternat Med. 2021, 5233462 (2021).","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref38","first-page":"6634837","type":"journal-article","article-title":"Total flavonoids of Rhizoma Drynariae restore the MMP\/TIMP balance in models of osteoarthritis by inhibiting the activation of the NF-\u03ba\u03b2 and PI3K\/AKT pathways","volume":"2021","author":"Chen","year":"2021","unstructured":"Chen, G. Y. et al. Total flavonoids of Rhizoma Drynariae restore the MMP\/TIMP balance in models of osteoarthritis by inhibiting the activation of the NF-\u03ba\u03b2 and PI3K\/AKT pathways. Evid Based Complement Alternat Med. 2021, 6634837 (2021).","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2147\/DDDT.S354946","type":"journal-article","article-title":"Network pharmacology analysis and experimental validation to investigate the mechanism of total flavonoids of Rhizoma Drynariae in treating rheumatoid arthritis","volume":"16","author":"Chen","year":"2022","unstructured":"Chen, G. Y. et al. Network pharmacology analysis and experimental validation to investigate the mechanism of total flavonoids of Rhizoma Drynariae in treating rheumatoid arthritis. Drug Des Devel Ther. 16, 1743-1766 (2022).","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.14530","type":"journal-article","article-title":"Prostaglandin-cytokine crosstalk in chronic inflammation","volume":"176","author":"Yao","year":"2019","unstructured":"Yao, C. Narumiya, S. Prostaglandin-cytokine crosstalk in chronic inflammation. Br J Pharmacol. 176 (3), 337-354 (2019).","journal-title":"Br J Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"152925","DOI":"10.1016\/j.phymed.2019.152925","type":"journal-article","article-title":"NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies","volume":"64","author":"Liu","year":"2019","unstructured":"Liu, P. et al. NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies. Phytomedicine. 64, 152925 (2019).","journal-title":"Phytomedicine"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"e20190613","DOI":"10.1084\/jem.20190613","type":"journal-article","article-title":"PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning stat3 activation","volume":"217","author":"Damasceno","year":"2020","unstructured":"Damasceno, L. E. A. et al. PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning stat3 activation. J Exp Med. 217 (10), e20190613 (2020).","journal-title":"J Exp Med"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","type":"journal-article","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: Current and future prospects","volume":"77","author":"Banerjee","year":"2017","unstructured":"Banerjee, S., Biehl, A., Gadina, M., Hasni, S., Schwartz, D. M. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: Current and future prospects. Drugs. 77 (5), 521-546 (2017).","journal-title":"Drugs"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10555-020-09883-w","type":"journal-article","article-title":"FOXO transcription factor family in cancer and metastasis","volume":"39","author":"Jiramongkol","year":"2020","unstructured":"Jiramongkol, Y. Lam, E. W. FOXO transcription factor family in cancer and metastasis. Cancer Metastasis Rev. 39 (3), 681-709 (2020).","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","type":"journal-article","article-title":"Targeting cell death pathways for cancer therapy: Recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","unstructured":"Tong, X. et al. Targeting cell death pathways for cancer therapy: Recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 15 (1), 174 (2022).","journal-title":"J Hematol Oncol"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/1878-0261.12807","type":"journal-article","article-title":"Cellular senescence in cancer: From mechanisms to detection","volume":"15","author":"Ou","year":"2021","unstructured":"Ou, H. L. et al. Cellular senescence in cancer: From mechanisms to detection. Mol Oncol. 15 (10), 2634-2671 (2021).","journal-title":"Mol Oncol"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2020-218467","type":"journal-article","article-title":"Interleukin 6 receptor inhibition in primary Sjogren syndrome: A multicentre double-blind randomised placebo-controlled trial","volume":"80","author":"Felten","year":"2021","unstructured":"Felten, R. et al. Interleukin 6 receptor inhibition in primary Sjogren syndrome: A multicentre double-blind randomised placebo-controlled trial. Ann Rheum Dis. 80 (3), 329-338 (2021).","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12974-019-1502-8","type":"journal-article","article-title":"Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjogren's syndrome","volume":"16","author":"Bardsen","year":"2019","unstructured":"Bardsen, K. et al. Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjogren's syndrome. J Neuroinflammation. 16 (1), 102 (2019).","journal-title":"J Neuroinflammation"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/rheumatology\/keaa670","type":"journal-article","article-title":"Tofacitinib counteracts il-6 overexpression induced by deficient autophagy: Implications in Sjogren's syndrome","volume":"60","author":"Barrera","year":"2021","unstructured":"Barrera, M. J. et al. Tofacitinib counteracts il-6 overexpression induced by deficient autophagy: Implications in Sjogren's syndrome. Rheumatology (Oxford). 60 (4), 1951-1962 (2021).","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"ref50","doi-asserted-by":"crossref","first-page":"586","DOI":"10.21037\/atm-22-1112","type":"journal-article","article-title":"ASPM and TROAP gene expression as potential malignant tumor markers","volume":"10","author":"Liu","year":"2022","unstructured":"Liu, H., Zhou, Q., Xu, X., Du, Y., Wu, J. ASPM and TROAP gene expression as potential malignant tumor markers. Ann Transl Med. 10 (10), 586 (2022).","journal-title":"Ann Transl Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biopha.2015.08.004","type":"journal-article","article-title":"CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients","volume":"74","author":"Qian","year":"2015","unstructured":"Qian, X. et al. CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients. Biomed Pharmacother. 74, 222-227 (2015).","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5301\/JBM.2010.6088","type":"journal-article","article-title":"Use of serum circulating CCNB2 in cancer surveillance","volume":"25","author":"Mo","year":"2010","unstructured":"Mo, M. L. et al. Use of serum circulating CCNB2 in cancer surveillance. Int J Biol Markers. 25 (4), 236-242 (2010).","journal-title":"Int J Biol Markers"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.cellsig.2007.05.017","type":"journal-article","article-title":"NuSAP is degraded by APC\/C-Cdh1 and its overexpression results in mitotic arrest dependent of its microtubules' affinity","volume":"19","author":"Li","year":"2007","unstructured":"Li, L. et al. NuSAP is degraded by APC\/C-Cdh1 and its overexpression results in mitotic arrest dependent of its microtubules' affinity. Cell Signal. 19 (10), 2046-2055 (2007).","journal-title":"Cell Signal"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.devcel.2005.09.003","type":"journal-article","article-title":"Cdk1\/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, cep55, is required for its recruitment to midbody and cytokinesis","volume":"9","author":"Fabbro","year":"2005","unstructured":"Fabbro, M. et al. Cdk1\/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell. 9 (4), 477-488 (2005).","journal-title":"Dev Cell"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/onc.2015.128","type":"journal-article","article-title":"Beyond cytokinesis: The emerging roles of CEP55 in tumorigenesis","volume":"35","author":"Jeffery","year":"2016","unstructured":"Jeffery, J., Sinha, D., Srihari, S., Kalimutho, M., Khanna, K. K. Beyond cytokinesis: The emerging roles of CEP55 in tumorigenesis. Oncogene. 35 (6), 683-690 (2016).","journal-title":"Oncogene"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"983","DOI":"10.21037\/tcr-20-2570","type":"journal-article","article-title":"Overexpression of abnormal spindle-like microcephaly-associated (ASPM) increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma","volume":"10","author":"Feng","year":"2021","unstructured":"Feng, Z. et al. Overexpression of abnormal spindle-like microcephaly-associated (ASPM) increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma. Transl Cancer Res. 10 (2), 983-997 (2021).","journal-title":"Transl Cancer Res"},{"issue":"14","key":"ref57","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.7150\/ijbs.80017","type":"journal-article","article-title":"Comprehensive pan-cancer analysis reveals NuSAP1 is a novel predictive biomarker for prognosis and immunotherapy response","volume":"19","author":"Zheng","year":"2023","unstructured":"Zheng, H. et al. Comprehensive pan-cancer analysis reveals NuSAP1 is a novel predictive biomarker for prognosis and immunotherapy response. Int J Biol Sci. 19 (14), 4689-4708 (2023).","journal-title":"Int J Biol Sci"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","type":"journal-article","article-title":"Epithelial-immune cell interplay in primary sjogren syndrome salivary gland pathogenesis","volume":"17","author":"Verstappen","year":"2021","unstructured":"Verstappen, G. M., Pringle, S., Bootsma, H., Kroese, F. G. M. Epithelial-immune cell interplay in primary sjogren syndrome salivary gland pathogenesis. Nat Rev Rheumatol. 17 (6), 333-348 (2021).","journal-title":"Nat Rev Rheumatol"},{"issue":"52","key":"ref59","doi-asserted-by":"crossref","first-page":"16000","DOI":"10.1073\/pnas.1507294112","type":"journal-article","article-title":"Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1","volume":"112","author":"El Rayes","year":"2015","unstructured":"El Rayes, T. et al. Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1. Proc Natl Acad Sci U S A. 112 (52), 16000-16005 (2015).","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"27007","DOI":"10.1289\/EHP9688","type":"journal-article","article-title":"PM2.5 and serum metabolome and insulin resistance, potential mediation by the gut microbiome: A population-based panel study of older adults in china","volume":"130","author":"Zhao","year":"2022","unstructured":"Zhao, L. et al. PM2.5 and serum metabolome and insulin resistance, potential mediation by the gut microbiome: A population-based panel study of older adults in china. Environ Health Perspect. 130 (2), 27007 (2022).","journal-title":"Environ Health Perspect"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"137432","DOI":"10.1016\/j.scitotenv.2020.137432","type":"journal-article","article-title":"PM2.5 exposure perturbs lung microbiome and its metabolic profile in mice","volume":"721","author":"Li","year":"2020","unstructured":"Li, J. et al. PM2.5 exposure perturbs lung microbiome and its metabolic profile in mice. Sci Total Environ. 721 137432 (2020).","journal-title":"Sci Total Environ"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12865-024-00605-3","type":"journal-article","article-title":"Network pharmacology-based strategy to investigate the mechanisms of artemisinin in treating primary sjogren's syndrome","volume":"25","author":"Liao","year":"2024","unstructured":"Liao, J. H. et al. Network pharmacology-based strategy to investigate the mechanisms of artemisinin in treating primary sjogren's syndrome. BMC Immunol. 25 (1), 16 (2024).","journal-title":"BMC Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1110765","DOI":"10.3389\/fbioe.2023.1110765","type":"journal-article","article-title":"JAK\/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens","volume":"11","author":"Hu","year":"2023","unstructured":"Hu, Q. et al. JAK\/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. Front Bioeng Biotechnol. 11, 1110765 (2023).","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","type":"journal-article","article-title":"Evolving cognition of the JAK-STAT signaling pathway: Autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","unstructured":"Xue, C. et al. Evolving cognition of the JAK-STAT signaling pathway: Autoimmune disorders and cancer. Signal Transduct Target Ther. 8 (1), 204 (2023).","journal-title":"Signal Transduct Target Ther"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/67421\/primary-sjogren-s-syndrome-associated-with-lung-adenocarcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:04:48Z","timestamp":1792598688000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/67421\/primary-sjogren-s-syndrome-associated-with-lung-adenocarcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":64,"journal-issue":{"issue":"211","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3791\/67421","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]}}}